October 30, 2018 - PathoVacs awarded United States Patent (Patent No.: US 10,114,025) for the invention "Means and Methods for Producing Anti-Proteome Antibodies and Identifying Conserved Unique or Differentially Expressing Molecules of Organisms."
February 13, 2019- Provisional US Patent Application 62/804,805 "Alpha-synuclein-based nano-theranostics for Parkinson’s disease," filed on February 13, 2019.
Pathovacs, Inc. 1024 Roy J. Carver Co-Laboratory Iowa State University Ames, IA50011 United States information@pathovacs.com